Mark Christopher Murray Avantor, Inc. (AVTR) insider trading activity

Mark Christopher Murray is EVP, Biomaterials & AT of Avantor, Inc.. Currently has a direct ownership of 18,680 shares of AVTR, which is worth approximately $477,087. The most recent transaction as insider was on Jan 13, 2022, when has been sold 918 shares (Common Stock) at a price of $37.5 per share, resulting in proceeds of $34,425. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.7K

0% 3M change

0% 12M change

Total Value Held $477,087

Mark Christopher Murray Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 13 2022	SELL Payment of exercise price or tax liability	$34,425 $37.5 p/Share	918 Reduced 4.68%	18,680 Common Stock
Feb 25 2021	BUY Grant, award, or other acquisition	-	8,140 Added 29.35%	19,598 Common Stock
Jan 13 2021	SELL Payment of exercise price or tax liability	$26,806 $29.2 p/Share	918 Reduced 7.42%	11,458 Common Stock

Also insider at

Celanese Corp Basic Materials

SVP - Acetyls

MCM